What We’re Reading: Health Insurers to Cut PA Process; Bipartisan Bill to Stop MA Overpayments; J&J Ends RSV Vaccine Work
Payers are looking to roll back on paperwork requirements for prior authorization (PA); CMS and Medicare Advantage (MA) insurers battle over new regulations; Johnson & Johnson (J&J) falls behind Pfizer and GSK for vaccine approval.
Health Insurers Seek to Reduce Medical Paperwork Due to Prior Authorization
UnitedHealthcare, Cigna, and Aetna have announced new cuts to their use of the prior authorization process,
Bipartisan Bill Aims to Stop MA Up-coding Practices Leading to Overpayments
New legislation hopes to stop overpayments to Medicare Advantage (MA) plans after feuding with the CMS over risk adjustment,
J&J Ducks Out of Race for Approval of the World’s First RSV Vaccine
Johnson & Johnson (J&J) announced that it is backing out of the race for approval of the world’s first respiratory syndactyl virus (RSV) vaccine,
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Related Articles
- Promising Early Efgartigimod Response Data for Generalized Myasthenia Gravis
September 18th 2025
- Metabolic Issues More Common in Patients With HIV
September 18th 2025
- Barriers to Gender-Affirming Surgery Persist Despite High Satisfaction Rate
September 18th 2025
- Eating Behaviors May Predict GLP-1 Therapy Success in Type 2 Diabetes
September 18th 2025